EdgarLookup

TriSalus Life Sciences, Inc. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that TriSalus Life Sciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Revenue — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $11.57M Nov 13, 2025
Q2 2025 Jun 30, 2025 $11.21M Aug 12, 2025
Q1 2025 Mar 31, 2025 $9.17M May 15, 2025
Q3 2025 Sep 30, 2024 $7.35M Nov 13, 2025
Q2 2025 Jun 30, 2024 $7.36M Aug 12, 2025
Q1 2025 Mar 31, 2024 $6.46M May 15, 2025
Q3 2024 Sep 30, 2023 $5.19M Nov 14, 2024
Q2 2024 Jun 30, 2023 $4.61M Aug 14, 2024
Q1 2024 Mar 31, 2023 $2.98M May 15, 2024
Q3 2023 Sep 30, 2022 $3.92M Nov 14, 2023

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($10.81M) Nov 13, 2025
Q3 2025 Jun 30, 2025 ($8.29M) Nov 13, 2025
Q2 2025 Jun 30, 2025 ($8.29M) Aug 12, 2025
Q2 2025 Mar 31, 2025 ($10.38M) Aug 12, 2025
Q3 2025 Mar 31, 2025 ($10.38M) Nov 13, 2025
Q1 2025 Mar 31, 2025 ($10.38M) May 15, 2025
Q3 2025 Sep 30, 2024 ($2.40M) Nov 13, 2025
Q3 2025 Jun 30, 2024 ($4.33M) Nov 13, 2025
Q2 2025 Jun 30, 2024 ($4.33M) Aug 12, 2025
Q1 2025 Mar 31, 2024 ($13.21M) May 15, 2025
Q2 2025 Mar 31, 2024 ($13.21M) Aug 12, 2025
Q3 2025 Mar 31, 2024 ($13.21M) Nov 13, 2025
Q3 2024 Sep 30, 2023 ($1.43M) Nov 14, 2024
Q2 2024 Jun 30, 2023 ($13.97M) Aug 14, 2024
Q3 2024 Jun 30, 2023 ($13.99M) Nov 14, 2024
Q3 2024 Mar 31, 2023 ($8.31M) Nov 14, 2024
Q1 2024 Mar 31, 2023 ($8.27M) May 15, 2024
Q2 2024 Mar 31, 2023 ($8.27M) Aug 14, 2024
Q3 2023 Sep 30, 2022 ($8.09M) Nov 14, 2023
Q3 2023 Jun 30, 2022 ($8.68M) Nov 14, 2023

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($9.01M) Nov 13, 2025
Q2 2025 Jun 30, 2025 ($7.33M) Aug 12, 2025
Q1 2025 Mar 31, 2025 ($7.33M) May 15, 2025
Q3 2025 Sep 30, 2024 ($8.74M) Nov 13, 2025
Q2 2025 Jun 30, 2024 ($8.17M) Aug 12, 2025
Q1 2025 Mar 31, 2024 ($11.67M) May 15, 2025
Q3 2024 Mar 31, 2024 ($11.67M) Nov 14, 2024
Q3 2024 Sep 30, 2023 ($18.62M) Nov 14, 2024
Q2 2024 Jun 30, 2023 ($11.43M) Aug 14, 2024
Q1 2024 Mar 31, 2023 ($10.12M) May 15, 2024
Q3 2023 Sep 30, 2022 ($8.11M) Nov 14, 2023
Q2 2023 Jun 30, 2022 ($288.3K) Aug 2, 2023
Q1 2023 Mar 31, 2022 ($669.8K) May 12, 2023
Q3 2022 Sep 30, 2021 ($807.3K) Nov 10, 2022
Q2 2022 Jun 30, 2021 ($783.9K) Aug 10, 2022
Q1 2022 Mar 31, 2021 ($308.0K) May 11, 2022
Q3 2021 Sep 30, 2020 ($1.0K) Dec 13, 2021